[Federal Register Volume 87, Number 151 (Monday, August 8, 2022)]
[Notices]
[Page 48191]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16890]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Center for 
Advancing Translational Sciences Advisory Council.
    This meeting is being held virtually only; there is no in-person 
option. The open sessions will be videocast and may be accessed by the 
public from the NIH Videocasting and Podcasting website (http://videocast.nih.gov). Individuals who need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: September 22, 2022.
    Closed: 11:00 a.m. to 12:00 p.m.
    Agenda: To review, evaluate, and discuss internal operations. To 
review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, Room 987/989, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Open: 1:00 p.m. to 6:00 p.m.
    Agenda: Report from the Institute Director, program updates, 
view and discuss Clearance of Concepts.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, Room 987/989, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center for Advancing Translational Sciences, One 
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice no later than 15 days after the meeting at 
[email protected]. The statement should include the 
name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-16890 Filed 8-5-22; 8:45 am]
BILLING CODE 4140-01-P